Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists

Journal of Clinical Neuroscience

Volumn 14, Issue 12, 2007, Pages 1178-1181

  Singh, Asha ^a   Kandimala, Geetha ^a   Dewey Jr , Richard B ^a   O'Suilleabhain, Padraig ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Dopamine agonists; Gambling; Parkinson's disease

Indexed keywords

APOMORPHINE; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; PRAMIPEXOLE; ROPINIROLE;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; COMPULSION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PATIENT COUNSELING; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; COMPULSIVE BEHAVIOR; DATA COLLECTION; DOPAMINE AGONISTS; FEMALE; GAMBLING; HUMANS; LIBIDO; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SEXUAL BEHAVIOR;

EID: 36048976263     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.01.009     Document Type: Article

References (13)

1. Dodd M.L., Klos K.J., Bower J.H., et al. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 62 (2005) 1377-1381
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV TR). Washington, DC: American Psychiatric Association; 2000.
3. Litvan I., Bhatia K.P., Burn D.J., et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18 (2003) 467-486
4. Thobois S. Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature. Clin Ther 28 (2006) 1-12
5. Seedat S., Kesler S., Niehaus D.J., et al. Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents. Depress Anxiety 11 (2000) 185-186
6. Szarfman A., Doraiswamy P.M., Tonning J.M., et al. Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database. Arch Neurol 63 (2006) 299-300 author reply: 300
7. Driver-Dunckley E., Samanta J., and Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 61 (2003) 422-423
8. Voon V., Hassan K., Zurowski M., et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 66 (2006) 1750-1752
9. Weintraub D., Siderowf A.D., Potenza M.N., et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 63 (2006) 969-973
10. Pontone G., Williams J.R., Bassett S.S., et al. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 67 (2006) 1258-1261
11. Shaffer H.J., Hall M.N., and Vander Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Public Health 89 (1999) 1369-1376
12. Blanco C., Hasin D.S., Petry N., et al. Sex differences in subclinical and DSM-IV pathological gambling: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 36 (2006) 943-953
13. Voon V. Repetition, repetition, and repetition: compulsive and punding behaviors in Parkinson's disease. Mov Disord 19 (2004) 367-370